PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina

NCT00682565 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Myocardial Ischemia
Angina Pectoris

Interventions

DRUG: CK-1827452 24mg and 6 mg iv infusion
DRUG: CK-1827452 12.5mg capsule
DRUG: CK-1827452 48 mg and 11 mg iv infusion
DRUG: CK-1827452 25mg capsule
DRUG: Placebo iv infusion
DRUG: Placebo capsule

Sponsor

Cytokinetics